
Opinion|Videos|September 27, 2024
Understanding the Clinical Burden and Prevalence of Lupus Nephritis
Panelists discuss the significant clinical and economic burdens of lupus nephritis, including the increased risk of kidney failure and death, and provide current statistics on the prevalence and incidence of lupus nephritis in various populations.
Advertisement
Episodes in this series

Now Playing
- Lupus nephritis (LN) is associated with considerable clinical and economic burdens in affected patients. Describe the clinical burden of LN on patients and their caregivers.
- What are the current statistics on the prevalence and incidence of LN in different populations?
- How many patients have systemic lupus erythematosus (SLE)?
- How often do patients with SLE present with or develop LN?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
New Partnership Model Boosts Maternal Outcomes in Medicaid ACOs
3
Value-Based Care Interventions and Management of CKD Progression
4
Better Food, Better Health: Redefining Chronic Disease Care Through Nutrition
5